Christian Bartelmus

Christian Bartelmus

Auto-generated profile, based on publicly available information

Christian Bartelmus

Roche Pharma Research & Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, 4070 Basel, Switzerland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2023 in Nature Chemistry
Verified
Journal Article
Open access
PDF file
DNDavid F. Nippa
David F. Nippa
KAKenneth Atz
Kenneth Atz
RHRemo Hohler
Remo Hohler
AMAlex T. Müller
Alex T. Müller
AMAndreas Marx
Andreas Marx
GSGisbert Schneider
Gisbert Schneider
Late-stage functionalization is an economical approach to optimize the properties of drug candidates. However, the chemical complexity of drug molecules often makes late-stage diversification challenging. To address this problem, a late-stage functionalization platform based on geometric deep learning and high-throughput reaction screening was developed. Considering borylation as a critical step in late-stage functionalization, the computational model predicted reaction yields for diverse reaction conditions with a mean absolute error margin of 4–5%, while the reactivity of novel reactions with known and unknown substrates was classified with a balanced accuracy of 92% and 67%, respectively. The regioselectivity of the major products was accurately captured with a classifier F-score of 67%. When applied to 23 diverse commercial drug molecules, the platform successfully identified numerous opportunities for structural diversification. The influence of steric and electronic information on model performance was quantified, and a comprehensive simple user-friendly reaction format was introduced that proved to be a key enabler for seamlessly integrating deep learning and high-throughput experimentation for late-stage functionalization.

3 October 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BKBernd Kuhn
Bernd Kuhn
MRMartin Ritter
Martin Ritter
BHBenoit Hornsperger
Benoit Hornsperger
CBCharles Bell
Charles Bell
BKBuelent Kocer
Buelent Kocer
Uwe GretherUwe Grether
Uwe Grether

28 July 2025 in Acta Crystallographica Section D Structural Biology
Verified
Journal Article
Open access
AEAndreas Ehler
Andreas Ehler
CBChristian Bartelmus
Christian Bartelmus
JBJoerg Benz
Joerg Benz
IPInken Plitzko
Inken Plitzko
MRMarkus G. Rudolph
Markus G. Rudolph
FABP4 has been implicated as a therapeutic target for treating diabetes and atherosclerosis. Structure-based drug design (SBDD) based on initial hits from high-throughput and fragment screens yielded 216 ligand-bound structures of human FABP3, FABP4 and FABP5 isoforms, many of which were at resolutions of better than 1.2 Å. An estimated 15% of the ligands had a different chemical composition to that expected from the starting materials or the final synthesis product, highlighting a potential problem inherent to all SBDD campaigns conducted at lower resolution. Apart from possible human error during compound registration, side reactions such as additions, eliminations, isomerizations, cyclizations and dimerizations were found that led to compounds capable of binding to FABP.

18 March 2026 in Chemical Science
Verified
Journal Article
Open access
PDF file
RGRudolf L. Z. Ganzoni
Rudolf L. Z. Ganzoni
MKMiroslav Kosar
Miroslav Kosar
YHYongqi Han
Yongqi Han
RVRosa Maria Vitale
Rosa Maria Vitale
PAPietro Amodeo
Pietro Amodeo
ECErick Moran Carreira
Erick Moran Carreira
This study, exemplified at CB 2 R, showcases how strategic reutilization of a single ligand scaffold fine-tunes activity of a class A GPCR by virtue of targeting its toggle switch.

18 August 2026 in Organic Letters
Verified
Journal Article
Closed access
LULorenz Urner
Lorenz Urner
JKJoel Kym
Joel Kym
HPHelena D. Pickford
Helena D. Pickford
AOAnna Onyszczak
Anna Onyszczak
IKIsabel Kissling
Isabel Kissling
WHWolfgang Haap
Wolfgang Haap

8 October 2026 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BBBenjamin Brennecke
Benjamin Brennecke
LPLouise Plais
Louise Plais
BHBenoit Hornsperger
Benoit Hornsperger
MBMartin Binder
Martin Binder
CBChristian Bartelmus
Christian Bartelmus
Uwe GretherUwe Grether
Uwe Grether